|
US6455690B1
(en)
*
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
|
AU743366B2
(en)
*
|
1997-01-17 |
2002-01-24 |
Icn Pharmaceuticals, Inc. |
Novel nucleosides
|
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
|
WO2001027114A1
(en)
*
|
1999-08-27 |
2001-04-19 |
Icn Pharmaceuticals, Inc. |
PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
EP1964569A3
(en)
|
2000-04-13 |
2009-07-22 |
Pharmasset, Inc. |
3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
|
|
PY0111577A
(es)
*
|
2000-05-23 |
2017-01-02 |
Idenix Cayman Ltd |
Métodos y composiciones para el tratamiento del virus de la hepatitis c
|
|
AP2006003708A0
(en)
|
2000-05-26 |
2006-08-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flavivirusesand pestiviruses
|
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
|
US6858590B2
(en)
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
|
AU2001292151B2
(en)
|
2000-08-17 |
2006-05-04 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
|
US20030008841A1
(en)
*
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
EP2404603A1
(en)
*
|
2000-10-23 |
2012-01-11 |
Glaxosmithkline LLC |
Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
GB0114286D0
(en)
*
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US7049303B2
(en)
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
|
CN1300165C
(zh)
*
|
2001-11-27 |
2007-02-14 |
安那迪斯药品股份有限公司 |
3－β－呋喃核糖基噻唑并[4,5－d]嘧啶核苷及其应用
|
|
US7321033B2
(en)
*
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
AU2002364216A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza l-nucleosides
|
|
CN1678326A
(zh)
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
RU2005102096A
(ru)
*
|
2002-06-28 |
2005-11-20 |
Айденикс (Кайман) Лимитед (Ky) |
2'и 3'-нуклеозидные пролекарства для лечения инфекций, вызываемых flaviviridae
|
|
PT1523489E
(pt)
*
|
2002-06-28 |
2014-06-24 |
Centre Nat Rech Scient |
Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae
|
|
JP2006507235A
(ja)
|
2002-08-01 |
2006-03-02 |
フアーマセツト・インコーポレイテツド |
フラビウイルス科ウイルス感染治療のためのビシクロ［４．２．１］ノナン系を有する化合物
|
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
|
DE10238724A1
(de)
*
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
CN1293884C
(zh)
*
|
2002-10-29 |
2007-01-10 |
南京长澳医药科技有限公司 |
6－甲氧基双脱氧鸟苷在制备抗乙肝药物中的应用
|
|
RU2005118421A
(ru)
|
2002-11-15 |
2006-01-20 |
Айденикс (Кайман) Лимитед (Ky) |
2'-разветвленные нуклеозиды и мутация flaviviridae
|
|
PL377287A1
(pl)
|
2002-12-12 |
2006-01-23 |
Idenix (Cayman) Limited |
Sposób wytwarzania 2'-rozgałęzionych nukleozydów
|
|
WO2004084796A2
(en)
*
|
2003-03-28 |
2004-10-07 |
Pharmasset Ltd. |
Compounds for the treatment of flaviviridae infections
|
|
US8044060B2
(en)
*
|
2003-05-09 |
2011-10-25 |
Boehringer Ingelheim International Gmbh |
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
|
|
DE10320785A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
|
US7550442B2
(en)
*
|
2003-05-20 |
2009-06-23 |
The Board Of Trustees Of The University Of Illinois |
Nucleoside analog inhibitors of reverse transcriptase
|
|
WO2005020885A2
(en)
*
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
BRPI0419345B8
(pt)
*
|
2003-05-30 |
2021-05-25 |
Gilead Pharmasset Llc |
uso do (2r)-2-desoxi-2-flúor-2-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
|
|
DK1658302T3
(da)
|
2003-07-25 |
2010-11-22 |
Idenix Pharmaceuticals Inc |
Purinnukleosidanaloge til behandling af sygdomme forårsaget af Flavirividae, herunder hepatitis C
|
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
TW201245229A
(en)
|
2003-10-14 |
2012-11-16 |
Hoffmann La Roche |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
|
|
DE102004001873A1
(de)
|
2004-01-14 |
2005-09-29 |
Bayer Healthcare Ag |
Cyanopyrimidinone
|
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
CA2576030A1
(en)
*
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
|
MX2007003085A
(es)
|
2004-09-14 |
2007-08-02 |
Pharmasset Inc |
Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
|
|
US8133870B2
(en)
|
2004-10-29 |
2012-03-13 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
|
JP5303149B2
(ja)
*
|
2004-12-17 |
2013-10-02 |
アナディス ファーマシューティカルズ インク |
３，５−二置換及び３，５，７−三置換−３Ｈ−オキサゾロ及び３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オン化合物及びそのプロドラッグ
|
|
CA2594422A1
(en)
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
Pyrazolopyrimidines as cell cycle kinase inhibitors
|
|
EP1846408B1
(en)
|
2005-01-14 |
2013-03-20 |
Janssen Pharmaceutica NV |
5-membered annelated heterocyclic pyrimidines as kinase inhibitors
|
|
US7820637B2
(en)
*
|
2005-03-17 |
2010-10-26 |
Proyecto De Biomedicina Cima, S.L. |
Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
|
|
RU2393866C2
(ru)
*
|
2005-03-17 |
2010-07-10 |
Проекто Де Биомедисина Сима, С.Л. |
Применение 5'-метилтиоаденозина (мта) для предотвращения и/или лечения аутоиммунных заболеваний и/или отторжения трансплантата
|
|
PE20061351A1
(es)
*
|
2005-03-25 |
2007-01-14 |
Glaxo Group Ltd |
COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
|
|
EP1865959A2
(en)
*
|
2005-03-25 |
2007-12-19 |
Glaxo Group Limited |
Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
|
|
AU2006271164A1
(en)
*
|
2005-07-22 |
2007-01-25 |
Giuliani International Limited |
Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
|
|
ITRM20050391A1
(it)
*
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti analoghi della 6-tioguanosina trifosfato, loro uso in campo medico e procedimento per la loro preparazione.
|
|
DE602006015700D1
(de)
|
2005-11-21 |
2010-09-02 |
Anadys Pharmaceuticals Inc |
Neues verfahren zur herstellung von 5-amino-3h-thiazoloä4,5-düpyrimidin-2-on
|
|
TWI418561B
(zh)
*
|
2006-06-22 |
2013-12-11 |
Anadys Pharmaceuticals Inc |
５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
|
|
JP5225991B2
(ja)
|
2006-07-18 |
2013-07-03 |
アナディス ファーマシューティカルズ インク |
チアゾロ［４，５−ｄ］ピリミジンのカーボネート及びカルバメートプロドラッグ
|
|
JP2010510171A
(ja)
*
|
2006-08-21 |
2010-04-02 |
ユナイテッド セラピューティクス コーポレーション |
ウイルス感染症の治療のための併用療法
|
|
US7964580B2
(en)
*
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
WO2009022236A2
(en)
|
2007-08-16 |
2009-02-19 |
Tripep Ab |
Immunogen platform
|
|
EP2048151A1
(en)
*
|
2007-10-10 |
2009-04-15 |
Cilag AG |
Method for producing nucleosides by direct glycosylation of the nucleoside base
|
|
JP5498392B2
(ja)
|
2007-11-30 |
2014-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｃｎｓ障害の治療のためのｐｄｅ９ａモジュレーターとしてのそれらの使用
|
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
|
ES2329327B1
(es)
|
2008-03-19 |
2010-09-17 |
Proyecto De Biomedicina Cima, S.L. |
Combinaciones sinergicas de 5'-metiltioadenosina.
|
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
US20100004526A1
(en)
*
|
2008-06-04 |
2010-01-07 |
Eigen, Inc. |
Abnormality finding in projection images
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
WO2010022126A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Schering Corporation |
Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
WO2010027935A1
(en)
|
2008-09-08 |
2010-03-11 |
Merck Sharp & Dohme Corp. |
Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
|
|
CN102143965A
(zh)
|
2008-09-08 |
2011-08-03 |
贝林格尔.英格海姆国际有限公司 |
吡唑并嘧啶酮及其在治疗中枢神经系统疾病中的用途
|
|
WO2010039801A2
(en)
|
2008-10-02 |
2010-04-08 |
The J. David Gladstone Institutes |
Methods of treating hepatitis c virus infection
|
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
TW201026715A
(en)
|
2008-12-23 |
2010-07-16 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
|
JP6104504B2
(ja)
|
2008-12-23 |
2017-03-29 |
ギリアド ファーマセット エルエルシー |
ヌクレオシド類似体
|
|
US8975247B2
(en)
|
2009-03-18 |
2015-03-10 |
The Board Of Trustees Of The Leland Stanford Junion University |
Methods and compositions of treating a flaviviridae family viral infection
|
|
PT2414363E
(pt)
|
2009-03-31 |
2014-02-26 |
Boehringer Ingelheim Int |
Derivados de 1-heterociclil-1,5-di-hidro-pirazolo[3,4- d]pirimidin-4-ona e sua utilização como moduladores de pde9a
|
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
AR077859A1
(es)
|
2009-08-12 |
2011-09-28 |
Boehringer Ingelheim Int |
Compuestos para el tratamiento de trastornos del snc
|
|
CL2011000716A1
(es)
|
2010-03-31 |
2012-04-20 |
Gilead Pharmasset Llc |
Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
WO2012004917A1
(ja)
*
|
2010-07-06 |
2012-01-12 |
Kaminishi Hidenori |
神経突起伸長剤
|
|
UA110347C2
(uk)
|
2010-08-12 |
2015-12-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A
|
|
EP2619215B1
(en)
|
2010-09-22 |
2018-09-05 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
WO2012075140A1
(en)
|
2010-11-30 |
2012-06-07 |
Pharmasset, Inc. |
Compounds
|
|
US20130040971A1
(en)
|
2011-02-14 |
2013-02-14 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013009737A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
SI2709613T2
(sl)
|
2011-09-16 |
2020-12-31 |
Gilead Pharmasset LLC c/o Gilead Sciences, Inc. |
Postopki za zdravljenje HCV
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
AU2012347785B2
(en)
|
2011-12-06 |
2017-03-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating viral diseases
|
|
SG10201610936RA
(en)
|
2011-12-22 |
2017-02-27 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
HUE029038T2
(en)
|
2012-05-25 |
2017-01-30 |
Janssen Sciences Ireland Uc |
Uracil spirooxetan nucleosides
|
|
GEP201706757B
(en)
|
2012-12-21 |
2017-10-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
NZ729172A
(en)
|
2013-01-31 |
2018-06-29 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
|
JP2016529293A
(ja)
|
2013-08-27 |
2016-09-23 |
ギリアド ファーマセット エルエルシー |
２つの抗ウイルス化合物の組合せ製剤
|
|
JP6562908B2
(ja)
|
2013-10-11 |
2019-08-21 |
ヤンセン バイオファーマ インク． |
置換ヌクレオシド、置換ヌクレオチドおよびその類似体
|
|
WO2015086519A1
(en)
*
|
2013-12-09 |
2015-06-18 |
Ucb Biopharma Sprl |
Imidazopyridine derivatives as modulators of tnf activity
|
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
|
CN104497083B
(zh)
*
|
2014-05-12 |
2017-07-07 |
河南师范大学 |
具有抗寄生虫活性的核苷‑苯基丙烯酮杂化体及其制备方法和应用
|
|
BR112017006264A2
(pt)
|
2014-09-26 |
2017-12-12 |
Riboscience Llc |
derivados de nucleosídeo substituído com 4?-vinila como inibidores de replicação de rna do vírus sincitial respiratório
|
|
RS61612B1
(sr)
|
2014-12-08 |
2021-04-29 |
Hoffmann La Roche |
3-supstituisana 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-dion jedinjenja za lečenje i profilaksu virusne infekcije
|
|
GEP20217282B
(en)
|
2015-03-06 |
2021-08-10 |
Atea Pharmaceuticals Inc |
β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
|
|
SG11201706835WA
(en)
|
2015-03-16 |
2017-09-28 |
Hoffmann La Roche |
Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
|
|
EP3294745B1
(en)
|
2015-05-08 |
2020-01-01 |
H. Hoffnabb-La Roche Ag |
Novel oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection
|
|
WO2016180743A1
(en)
|
2015-05-12 |
2016-11-17 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
|
CN104844673B
(zh)
*
|
2015-06-04 |
2017-09-08 |
新乡学院 |
一种制备天然核苷水粉蕈素的方法
|
|
WO2017001307A1
(en)
|
2015-06-30 |
2017-01-05 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
|
MX391226B
(es)
|
2015-09-23 |
2025-03-21 |
Merck Sharp & Dohme Llc |
Inhibidores de transcriptasa inversa de nucleosido 4'-substituido y preparaciones de los mismos.
|
|
CN109311885A
(zh)
|
2016-03-24 |
2019-02-05 |
诺华股份有限公司 |
炔基核苷类似物作为人类鼻病毒的抑制剂
|
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
|
PT3512863T
(pt)
|
2016-09-07 |
2022-03-09 |
Atea Pharmaceuticals Inc |
Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
|
|
AU2018205994B2
(en)
|
2017-01-06 |
2021-09-09 |
F. Hoffmann-La Roche Ag |
Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
|
|
CN108329372B
(zh)
*
|
2017-01-20 |
2022-07-26 |
浙江省亚热带作物研究所 |
N6-(2-羟乙基)腺苷及其衍生物在制备治疗痛风药物中的应用
|
|
CN110248951B
(zh)
|
2017-02-01 |
2022-10-28 |
阿堤亚制药公司 |
用于治疗丙型肝炎病毒的核苷酸半硫酸盐
|
|
US11040975B2
(en)
|
2017-12-08 |
2021-06-22 |
Merck Sharp & Dohme Corp. |
Carbocyclic nucleoside reverse transcriptase inhibitors
|
|
WO2019200005A1
(en)
|
2018-04-10 |
2019-10-17 |
Atea Pharmaceuticals, Inc. |
Treatment of hcv infected patients with cirrhosis
|
|
SG11202011667WA
(en)
|
2018-05-25 |
2020-12-30 |
Primmune Therapeutics Inc |
Tlr7 agonists
|
|
CA3134613A1
(en)
|
2019-04-02 |
2020-10-08 |
Aligos Therapeutics, Inc. |
Compounds targeting prmt5
|
|
CN111973615A
(zh)
*
|
2019-05-22 |
2020-11-24 |
华东理工大学 |
一种治疗躁狂型精神障碍及精神分裂症的药物
|
|
PE20221324A1
(es)
|
2019-11-26 |
2022-09-09 |
Primmune Therapeutics Inc |
Agonistas del tlr7
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
AU2021224588B2
(en)
|
2020-02-18 |
2024-07-18 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI874791B
(zh)
|
2020-02-18 |
2025-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
US11691971B2
(en)
|
2020-06-19 |
2023-07-04 |
Incyte Corporation |
Naphthyridinone compounds as JAK2 V617F inhibitors
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
BR112023000047A2
(pt)
|
2020-07-02 |
2023-03-14 |
Incyte Corp |
Compostos de ureia tricíclicos como inibidores da v617f da jak2
|
|
WO2022006456A1
(en)
|
2020-07-02 |
2022-01-06 |
Incyte Corporation |
Tricyclic pyridone compounds as jak2 v617f inhibitors
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
WO2022140231A1
(en)
|
2020-12-21 |
2022-06-30 |
Incyte Corporation |
Deazaguaine compounds as jak2 v617f inhibitors
|
|
AR125273A1
(es)
|
2021-02-25 |
2023-07-05 |
Incyte Corp |
Lactamas espirocíclicas como inhibidores de jak2 v617f
|
|
JP7688152B2
(ja)
|
2021-04-16 |
2025-06-03 |
ギリアード サイエンシーズ， インコーポレイテッド |
アミドを使用してカルバヌクレオシドを調製する方法
|
|
BR112023026356A2
(pt)
|
2021-06-17 |
2024-03-05 |
Atea Pharmaceuticals Inc |
Método para tratar vírus da hepatite c ou uma condição resultante de uma infecção por hepatite c, combinação, uso da combinação, composição farmacêutica, e, kit para o tratamento de vírus da hepatite c
|
|
JP7719954B2
(ja)
|
2021-08-18 |
2025-08-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
リン脂質化合物並びにその製造方法及び使用方法
|
|
KR20240163688A
(ko)
|
2022-03-17 |
2024-11-19 |
인사이트 코포레이션 |
Jak2 v617f 억제제로서의 삼환계 우레아 화합물
|